Literature DB >> 11883887

Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.

A Anadón1, M R Martínez-Larrañaga, J Iturbe, M A Martínez, M J Díaz, M T Frejo, M Martínez.   

Abstract

The pharmacokinetic properties of ciprofloxacin and its metabolites were determined in healthy chickens after single i.v. and oral dosage of 8 mg ciprofloxacin kg(-1) bodyweight. After i.v. and oral administration, the plasma concentration-time graph was characteristic of a two-compartment open model. Mean (SD) elimination half-life and mean residence time of ciprofloxacin in plasma were 8.84 (2.13) and 8.54 (1.64) hours, respectively, after i.v. administration and 11.89 (1.95) and 13.32 (2.65) hours, respectively, after oral administration. Mean maximal plasma concentration of ciprofloxacin was 2.63 (0.20) microg ml(-1), and the interval from oral administration until maximum concentration was 0.36 (0.07) hours. The mean oral bioavailability of ciprofloxacin was found to be 69.12 (6.95) per cent. Ciprofloxacin was mainly converted to oxociprofloxacin and desethyleneciprofloxacin. Considerable kidney, liver, muscle and skin + fat tissue concentrations of ciprofloxacin and its metabolites oxociprofloxacin and desethyleneciprofloxacin were found when ciprofloxacin was administered orally (8 mg kg(-1) on 3 successive days). It was estimated that mean tissue concentrations of ciprofloxacin and its metabolites ranging between 0.011 to 0.75 microg g(-1) persisted for 5 days.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11883887     DOI: 10.1053/rvsc.2001.0494

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.

Authors:  Gareth Lewis; Albert Juhasz; Euan Smith
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-04       Impact factor: 4.223

2.  Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.

Authors:  Gareth Lewis; Albert Juhasz; Euan Smith
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-05       Impact factor: 4.223

3.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in male and female turkeys following intravenous and oral administration.

Authors:  D J Dimitrova; L D Lashev; St G Yanev; V T Pandova
Journal:  Vet Res Commun       Date:  2006-05       Impact factor: 2.459

4.  Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration.

Authors:  Débora Cristina Sampaio de Assis; Guilherme Resende da Silva; Isabela Pereira Lanza; Ana Cláudia Dos Santos Rossi Ribeiro; Ângela Maria Quintão Lana; Leonardo José Camargos Lara; Tadeu Chaves de Figueiredo; Silvana de Vasconcelos Cançado
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Validation of an UHPLC-MS/MS Method for Screening of Antimicrobial Residues in Eggs and Their Application to Analyses of Eggs from Laying Hens Subjected to Pharmacological Treatment.

Authors:  Letícia Gomes Magnago Caldeira; Flávio Alves Santos; Andréa Melo Garcia de Oliveira; Josefa Abucater Lima; Leonardo Francisco de Souza; Guilherme Resende da Silva; Débora Cristina Sampaio de Assis; Silvana de Vasconcelos Cançado
Journal:  J Anal Methods Chem       Date:  2017-10-23       Impact factor: 2.193

6.  The effects of different enrofloxacin dosages on clinical efficacy and resistance development in chickens experimentally infected with Salmonella Typhimurium.

Authors:  Jun Li; Haihong Hao; Guyue Cheng; Xu Wang; Saeed Ahmed; Muhammad Abu Bakr Shabbir; Zhenli Liu; Menghong Dai; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

7.  Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens.

Authors:  Karina P D Bonassa; Miwa Y Miragliotta; Rosineide C Simas; Marcos N Eberlin; Arturo Anadón; Ronilson A Moreno; Felix G R Reyes
Journal:  Front Vet Sci       Date:  2021-01-07

8.  Photodegradable antimicrobial agents - synthesis, photodegradation, and biological evaluation.

Authors:  Vebjørn Eikemo; Leiv K Sydnes; Magne O Sydnes
Journal:  RSC Adv       Date:  2021-09-30       Impact factor: 4.036

9.  Droplet Digital PCR-Based Detection and Quantification of GyrA Thr-86-Ile Mutation Based Fluoroquinolone-Resistant Campylobacter jejuni.

Authors:  Yi Luo; Wenting Zhang; Yiluo Cheng; Qin Lu; Yunqing Guo; Guoyuan Wen; Huabin Shao; Zhenyu Cheng; Qingping Luo; Tengfei Zhang
Journal:  Microbiol Spectr       Date:  2022-04-12

10.  Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.

Authors:  KaNa Sang; HaiHong Hao; LingLi Huang; Xu Wang; ZongHui Yuan
Journal:  Front Vet Sci       Date:  2016-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.